Trial to Examine the Effect of Natural Anti- Obesity Agent (Phaseolus Vulgaris) Among Women of Lahore
NCT ID: NCT05451927
Last Updated: 2024-04-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
72 participants
INTERVENTIONAL
2022-10-27
2023-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of a Supplement for Weight Management in Obese and Overweight Individuals
NCT03812211
Study To Determine The Effects And Safety Of A Weight Loss Compound On Overweight, Otherwise Healthy, Volunteers
NCT00479492
A Study Of 6-Month Duration To Evaluate The Weight Loss Effect Of Various Doses Of CP-945,598 In Obese Subjects
NCT00134199
Safety and Efficacy of IQP- AK-102 in Reducing Body Weight
NCT01905956
A Study to Evaluate the Efficacy and Safety of PF-06882961 in Adults With Obesity
NCT04707313
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Phaseolus Vulgaris
Three oral doses of 1000 mg Phaseolus Vulgaris daily for 3 months
Phaseolus Vulgaris
Weight loss
Placebo
Three oral doses of Placebo daily for 3 months
Placebo
Placebo
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Phaseolus Vulgaris
Weight loss
Placebo
Placebo
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Consistently stable body weight for at least 6 months
* Good general health
* No ongoing drug treatment for weight reduction
* Commitment to avoid any changes in lifestyle throughout the test period
* Age between 18-45 years
* Women resident of Lahore
Exclusion Criteria
* People with Type 2 diabetes
* People with any other chronic diseases
* Weight reduction treatment during the 6 months prior to the study
18 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of the Punjab
OTHER
Hafiza Aisha Sadiqa
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hafiza Aisha Sadiqa
Student
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Aisha Sadiqa, M.Phil
Role: PRINCIPAL_INVESTIGATOR
University of the Punjab
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Akhuwat Medical Centre
Lahore, Punjab Province, Pakistan
Niazi Medical Centre
Lahore, Punjab Province, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RCT012022
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.